Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in Ductal Carcinoma in Situ and Invasive Ductal Carcinoma of the Breast

참고문헌 (33)

1. "Metalloproteinases and tissue inhibitors of metalloproteinases", 52, pp.113~124 (1998)
2. "Matrix metal-loproteinase-2 immunoreactive protein: a marker of aggressiveness in breast carcinoma.", 83, pp.1153~1162 (1998)
3. "Matrix metalloproteinase-2 (MMP2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy", 65, pp.55~61 (2001)
4. "Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favorable indicator in node-negative patients", 84, pp.1488~1496 (2001)
5. "Matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9) type IV collagenase in colorectal cancer", 56, pp.190~196 (1996)
6. "Localization of messenger RNA for Mr 72 000 type IV collagenase in human skin cancers by in situ hybridization", pp.000 1336~41
7. "Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung", 47, pp.461~469 (1997)
8. "Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP)", 385, pp.238~240 (1996)
9. "Histologic grade and CD44 are independent predictors of axillary lymph node invasion in early (T1) breast cancer", 20, pp.319~330 (1999)
10. "Role of CD44 in nonpalpable T1a and T1b breast cancer", 28, pp.772~778 (1997)
11. "Glycoprotein CD44 expression and its association with survival in breast cancer", pp.867~74
12. "Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis", 14, pp.163~176 (2000)
13. "Nuclear structure in cancer tissues", pp.97~102
14. "Pathological prognostic factors in breast cancer. The value of histologic grade in breast cancer: experience from a large study with long-term follow-up", pp.403~10
15. "Matrix-metalloproteinases 1,2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study.", 435, pp.566~573 (1999)
16. "Expression of matrix metallo-proteinase-9 in vascular pericytes in human breast cancer", 77, pp.345~355 (1997)
17. "Assay of matrix metalloproteinase types 8 and 9 by ELISA in human breast cancer", 71, pp.1025~1028 (1995)
18. "Expression of gelatinase A and B, stromelysin-3 and matrilysin genes in breast carci-nomas: clinico-pathological correlations", 16, pp.577~585 (1998)
19. "Different expression patterns of MMP-2 and MMP-9 in breast cancer", 5, pp.875~9 (1998)
20. "Significance of membrane-type-1- matrix metalloproteinase expression in breast cancer", 90, pp.516~522 (1999)
21. "Expression of MMP-2 and MMP-9, their inhibitors and the activator MT1- MMP in primary breast carcinoma", 189, pp.161~168 (1999)
22. "Expression of matrix metalloprotei-nase-2 (MMP-2) and of membrane-type-1-matrix metalloproteinase (MT1-MMP) in transitional cell carci-noma of the upper urinary tract", 31, pp.193~200 (2000)
23. "High level of MT-MMP expression is associated with invasiveness of cervical cancer cells", 65, pp.209~213 (1996)
24. "MT-MMP expression and locali-zation in human lung and breast cancers", 428, pp.29~35 (1996)
25. "Expression and tissue localization of membrane-types 1 and 3 matrix metalloproteinases in human invasive breast carcinomas", 57, pp.2055~2060 (1997)
26. "an imbalance of positive and negative regulation", pp.5054~9
27. "Matrix metalloproteinase in tumour invasion and metastasis", 189, pp.300~308 (1999)
28. "Expression and prognostic significance of matrix metalloproteinases and their tissue inhibitors in primary neuroendocrine carcinoma of the skin", 34, pp.80~88 (2003)
29. "CD44 variant exon epitopes in primary breast cancer and length of survival", 345, pp.615~619 (1995)
30. "CD44v6 expression in non-Hodgkin's lymphoma: an association with low histologic grade and poor pro-gnosis", 176, pp.259~267 (1995)
31. "Splice variants of CD44 in human cervical cancer stage IB to IIB", 57, pp.383~387 (1995)
32. "Prognostic value of CD44 splice variant expression in ovarian cancer", 52, pp.400~406 (1995)
33. "Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins", pp.1470~2

관련 논문AI추천